Wednesday, June 24, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 919 of 1,261
  1. US 8197870

    Depolymerization extraction of compounds from birch bark

    Regents of the University of Minnesota · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  2. US 8197838

    Sustained release systems of ascorbic acid phosphate

    Advanced Technologies and Regenerative Medicine, LLC · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  3. US 8198042

    CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  4. US 8198244

    Regulation of skin characteristics by DICKKOPF1 (DKK1)

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  5. US 8198254

    Annexin A9 (ANXA9) biomarker and therapeutic target in epithelial cancer

    The Regents of the University of California · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  6. US 8198255

    SiRNA-mediated inhibition of doublecortin and Ca2+/calmodulin-dependent kinase-like-1

    The Board of Regents of the University of Oklahoma · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  7. US 8198402

    Smoothened polypeptides and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  8. US 8198406

    Methods and compositions for inhibiting angiogenesis

    Northwestern University · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  9. US 8198469

    Crystalline forms of tigecycline and processes for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  10. US 8198322

    Apoptotic and anti-tumor activities of metallo-salens

    The Board of Regents of the University of Texas System · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  11. US 8197818

    EML4-ALK fusion gene

    CUREGENE K.K. · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  12. US 8198242

    Variants of C-type natriuretic peptide

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted
  13. US 8193306

    Methods for preparing polymeric reagents and compositions of polymeric reagents

    Nektar Therapeutics · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  14. US 8193309

    Compositions and methods for preventing or treating cancer

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  15. US 8193352

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  16. US 8192741

    Method of treating rheumatoid arthritis with an anti-IL-6R antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  17. US 8193145

    Laminins, derivatives, and compositions including same and methods for their therapeutic use

    BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  18. US 8193202

    LIMK2 inhibitors, compositions comprising them, and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  19. US 8192991

    Methods of eliciting or boosting a cellular immune response

    The Regents of the University of California · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  20. US 8193225

    Isoxazole amides, derivatives and methods of chemical induction of neurogenesis

    The Board of Regents of the University of Texas System · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  21. US 8193197

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  22. US 8193204

    Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1- (4-chloro-2-(3-methyl-1H-pyrazol-1-YL)phenyl)2,2,2-trifluoroethoxy)-pyrimidin-4-YL)phenyl)propanoate and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  23. US 8193151

    Methods for treating atrial or ventricular arrhythmias

    Northwestern University · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  24. US 8193194

    Ion channel modulators and methods of use

    Vertex Pharmaceuticals Incorporated · Granted Jun 5, 2012 · Expires May 31, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.